D2G Oncology
UEI: CV5BLXMMLFJ3
• CAGE: 87FM3
Overview
Awardee Type
Parent
Company Description
D2G Oncology | Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics
Name
D2G Oncology
Website
Headquarters
Palo Alto, CA
United States
United States
Most Recent Award
Sept. 8, 2020
Calculating
Federal grant recipient
D2G ONCOLOGY, INC.
dba D2G ONCOLOGY INC
(UEI CV5BLXMMLFJ3, CAGE 87FM3)
is headquartered in Palo Alto CA.
The corporation
was founded in July 2018 and
federally registered in
November 2018.
Federal Award Analysis
D2G Oncology federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
D2G ONCOLOGY, INC.
DBA
D2G ONCOLOGY INC
UEI
CV5BLXMMLFJ3
CAGE Code
87FM3
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
July 1, 2018
Initial Registration
Nov. 15, 2018
Last Registration
Feb. 6, 2024
Registration Activation
Feb. 8, 2023
Registration Expiration
Feb. 6, 2024
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No